Paion Financial Statements From 2010 to 2025
| PAIOFDelisted Stock | USD 0.02 0.00 0.00% |
Check Paion AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Paion AG's main balance sheet or income statement drivers, such as , as well as many indicators such as . Paion financial statements analysis is a perfect complement when working with Paion AG Valuation or Volatility modules.
Paion |
Paion AG Company Return On Equity Analysis
Paion AG's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Paion AG Return On Equity | -0.0965 |
Most of Paion AG's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Paion AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Paion AG has a Return On Equity of -0.0965. This is 99.6% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 68.87% lower than that of the firm.
Paion AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Paion AG's current stock value. Our valuation model uses many indicators to compare Paion AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paion AG competition to find correlations between indicators driving Paion AG's intrinsic value. More Info.Paion AG is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Paion AG's earnings, one of the primary drivers of an investment's value.About Paion AG Financial Statements
Paion AG stakeholders use historical fundamental indicators, such as Paion AG's revenue or net income, to determine how well the company is positioned to perform in the future. Although Paion AG investors may analyze each financial statement separately, they are all interrelated. For example, changes in Paion AG's assets and liabilities are reflected in the revenues and expenses on Paion AG's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Paion AG. Please read more on our technical analysis and fundamental analysis pages.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. Paion AG was founded in 2000 and is based in Aachen, Germany. Paion Ag operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 64 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Paion Pink Sheet
If you are still planning to invest in Paion AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paion AG's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |